(Q36929844)

17 August 2017

Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma (English)

1 reference

17 August 2017

0 references

47

1 reference

17 August 2017

49

Ulrich Schüller

0 references

Karel Zitterbart

48

Karel Zitterbart

1 reference

17 August 2017

61

Uri Tabori

0 references

Almos Klekner

23

Almos Klekner

1 reference

17 August 2017

56

David Malkin

0 references

Nada Jabado

36

Nada Jabado

0 references

Janet C Lindsey

Janet C Lindsey

51

0 references

Pedro Castelo-Branco

Pedro Castelo-Branco

7

0 references

Dominik Sturm

Dominik Sturm

15

0 references

Trevor J Pugh

Trevor J Pugh

16

0 references

Wiesława Grajkowska

Wieslawa A Grajkowska

32

0 references

William A Weiss

William A Weiss

34

0 references

Marc Remke

Marc Remke

3

0 references

Stefan M. Pfister

Stefan Pfister

59

0 references

Maryam Fouladi

29

Maryam Fouladi

1 reference

17 August 2017

10

Eric Bouffet

1 reference

17 August 2017

55

Cynthia Hawkins

1 reference

17 August 2017

27

Charles G Eberhart

1 reference

17 August 2017

21

Stefan Rutkowski

1 reference

17 August 2017

20

Marco Gessi

1 reference

17 August 2017

14

Marcel Kool

1 reference

17 August 2017

13

Paul A Northcott

1 reference

17 August 2017

58

Andrey Korshunov

1 reference

17 August 2017

12

David T W Jones

1 reference

17 August 2017

43

Linda M Liau

2 references

ORCID Public Data File 2021

17 August 2017

5

David J H Shih

1 reference

17 August 2017

60

Michael D Taylor

1 reference

17 August 2017

17

Scott L Pomeroy

1 reference

17 August 2017

45

Ian F Pollack

1 reference

17 August 2017

42

Joshua B Rubin

1 reference

17 August 2017

11

André O von Bueren

1 reference

17 August 2017

18

Yoon-Jae Cho

1 reference

17 August 2017

4

Elke Pfaff

1 reference

17 August 2017

57

Steven C Clifford

1 reference

17 August 2017

37

Anne Jouvet

1 reference

17 August 2017

1

Nataliya Zhukova

1 reference

17 August 2017

2

Vijay Ramaswamy

1 reference

17 August 2017

6

Dianna C Martin

1 reference

17 August 2017

8

Berivan Baskin

1 reference

17 August 2017

24

Byung-Kyu Cho

1 reference

17 August 2017

33

Nalin Gupta

1 reference

17 August 2017

39

Toshihiro Kumabe

1 reference

17 August 2017

41

Jeffrey R Leonard

1 reference

17 August 2017

44

Luca Massimi

1 reference

17 August 2017

26

Kyu-Chang Wang

1 reference

17 August 2017

Peter N Ray

9

1 reference

17 August 2017

Torsten Pietsch

19

1 reference

17 August 2017

Laszlo Bognar

22

1 reference

17 August 2017

Seung-Ki Kim

25

1 reference

17 August 2017

Michelle Fevre-Montange

28

1 reference

17 August 2017

Pim J French

30

1 reference

17 August 2017

Max Kros

31

1 reference

17 August 2017

Peter Hauser

35

1 reference

17 August 2017

Shin Jung

38

1 reference

17 August 2017

Boleslaw Lach

40

1 reference

17 August 2017

Young Shin Ra

46

1 reference

17 August 2017

Rebecca M Hill

50

1 reference

17 August 2017

Ed C Schwalbe

52

1 reference

17 August 2017

Simon Bailey

53

1 reference

17 August 2017

David W Ellison

54

1 reference

17 August 2017

language of work or name

English

0 references

publication date

8 July 2013

1 reference

Journal of Clinical Oncology

17 August 2017

1 reference

17 August 2017

31

1 reference

17 August 2017

23

1 reference

17 August 2017

2927-2935

1 reference

Dissecting the genomic complexity underlying medulloblastoma

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Novel mutations target distinct subgroups of medulloblastoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

The clinical implications of medulloblastoma subgroups

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Molecular subgroups of medulloblastoma: the current consensus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Rapid diagnosis of medulloblastoma molecular subgroups

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Medulloblastoma comprises four distinct molecular variants

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

A clinicobiological model predicting survival in medulloblastoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

A bootstrap resampling procedure for model building: Application to the cox regression model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Adult medulloblastoma comprises three major molecular variants.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

TP53 mutations in favorable-risk Wnt/Wingless-subtype medulloblastomas.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Expression of p53 and prognosis in children with malignant gliomas.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878050

Germ-line mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23835706

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23835706

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23835706

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2012.48.5052

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

23835706

1 reference